DE3752158D1 - Molekulare Klonierung und Expression von menschlichem IL-3 - Google Patents

Molekulare Klonierung und Expression von menschlichem IL-3

Info

Publication number
DE3752158D1
DE3752158D1 DE3752158T DE3752158T DE3752158D1 DE 3752158 D1 DE3752158 D1 DE 3752158D1 DE 3752158 T DE3752158 T DE 3752158T DE 3752158 T DE3752158 T DE 3752158T DE 3752158 D1 DE3752158 D1 DE 3752158D1
Authority
DE
Germany
Prior art keywords
hil
expression
human
molecular cloning
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3752158T
Other languages
English (en)
Other versions
DE3752158T2 (de
Inventor
Lambertus Christiaan Dorssers
Gerard Dr Wagemaker
Yvonne Johanna Vos
Leen Robert Willem Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Application granted granted Critical
Publication of DE3752158D1 publication Critical patent/DE3752158D1/de
Publication of DE3752158T2 publication Critical patent/DE3752158T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3752158T 1986-12-16 1987-12-16 Molekulare Klonierung und Expression von menschlichem IL-3 Expired - Fee Related DE3752158T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86202285 1986-12-16
EP87201322 1987-07-13

Publications (2)

Publication Number Publication Date
DE3752158D1 true DE3752158D1 (de) 1998-02-12
DE3752158T2 DE3752158T2 (de) 1998-05-20

Family

ID=26103432

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3752158T Expired - Fee Related DE3752158T2 (de) 1986-12-16 1987-12-16 Molekulare Klonierung und Expression von menschlichem IL-3

Country Status (14)

Country Link
JP (2) JPH01502157A (de)
AT (1) ATE161882T1 (de)
AU (1) AU617095B2 (de)
CA (1) CA1341503C (de)
DE (1) DE3752158T2 (de)
ES (1) ES2113338T3 (de)
FI (1) FI102293B (de)
GR (1) GR3025857T3 (de)
IE (1) IE81129B1 (de)
IL (1) IL84852A (de)
NO (1) NO180544C (de)
NZ (1) NZ222939A (de)
PT (1) PT86381B (de)
WO (1) WO1988004691A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US6238889B1 (en) 1986-12-16 2001-05-29 Dsm N.V. Molecular cloning and expression of the Pro8 isoform of human IL-3
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
GB2210883B (en) * 1987-10-08 1992-01-02 British Bio Technology Synthetic interleukin-3 gene
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
JPH04500508A (ja) * 1988-07-20 1992-01-30 イミュネックス・コーポレーション 非グリコシル化　ヒト　インターロイキン―３　組成物
NZ232913A (en) * 1989-03-15 1992-08-26 Gist Brocades Nv Il-3 produced recombinantly and purified to homogeneity; vectors and pharmaceutical preparations
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
ES2106017T3 (es) 1989-08-14 1997-11-01 Gist Brocades Nv Mutantes de interleucina-3 humana.
US5516512A (en) 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
EP0596881B1 (de) * 1991-08-01 1997-03-19 Fondation Nationale De Transfusion Sanguine Expression in nicht-tumorbildenden menschlichen Lymphoblasten Zellinien mit einem integrierenden Vektor
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
DK0672145T3 (da) * 1992-11-24 2003-08-11 Searle & Co Interleukin-3-(IL-3)-polypeptider med flere mutationer
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
AU2866599A (en) * 1998-02-17 1999-08-30 Hyseq, Inc. A novel interleukin-3 and uses thereof
EP1848738A1 (de) * 2005-01-25 2007-10-31 Apollo Life Sciences Limited Parameterausgewählte gm-csf, il-3, il-4, il-5 und chimären davon für therapeutische und diagnostische zwecke
US8361750B2 (en) * 2006-04-03 2013-01-29 New England Biolabs, Inc. rBSA from K. lactis expression, secretion and purification of recombinant bovine serum albumin (rBSA) from K. lactis and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
AU570762B2 (en) * 1983-12-23 1988-03-24 Australian National University, The Cloning of cdna for il-3
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors

Also Published As

Publication number Publication date
FI102293B1 (fi) 1998-11-13
IE873409L (en) 1988-06-12
WO1988004691A1 (en) 1988-06-30
IL84852A (en) 1994-06-24
AU617095B2 (en) 1991-11-21
NO883614L (no) 1988-08-12
PT86381B (pt) 1990-11-20
AU1057788A (en) 1988-07-15
NZ222939A (en) 1991-03-26
NO883614D0 (no) 1988-08-12
ES2113338T3 (es) 1998-05-01
FI883688A (fi) 1988-08-08
FI883688A0 (fi) 1988-08-08
GR3025857T3 (en) 1998-04-30
JPH1080286A (ja) 1998-03-31
DE3752158T2 (de) 1998-05-20
CA1341503C (en) 2006-04-04
JPH01502157A (ja) 1989-08-03
ATE161882T1 (de) 1998-01-15
IE81129B1 (en) 2000-03-22
NO180544B (no) 1997-01-27
FI102293B (fi) 1998-11-13
NO180544C (no) 1997-05-07
IL84852A0 (en) 1988-06-30
PT86381A (en) 1988-01-01

Similar Documents

Publication Publication Date Title
DE3752158D1 (de) Molekulare Klonierung und Expression von menschlichem IL-3
ATE100209T1 (de) Antikoerper verwendende diagnostische methoden.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
PT93082A (pt) Processo de producao de um derivado de activador de plaminogenio tissular, de plasmideo de expressao e de medicamento contendo o referido derivado
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
BR9007115A (pt) Novo trombolitico
ATE79254T1 (de) Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
DE68918479D1 (de) Menschlicher Hitzeschock-Faktor.
DE59704194D1 (de) Verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren zur herstellung von arzneimitteln
ATE164882T1 (de) Verfahren zur herstellung von aktivierten killer- monozyten und verfahren zur überprüfung ihrer tumoriziden aktivität
ATE80306T1 (de) Mittel zur absorptionsverbesserung von proteinen.
FR2623628B1 (fr) Serum etalon, de nature humaine, reconstitue a partir des fractions rejetees (non utilisees en therapeutique), du fractionnement du plasma humain, du sang humain, du sang placentaire ou retroplacentaire
BG44874A3 (bg) Метод за получаване на кондензирани аs-триазини
KR900701834A (ko) 사람 호중구 화학주성 인자를 사람에게 투여하는 것에 의한 면역결핍 상태에 의해 유발된 질병의 치료방법
Tompkins et al. Relationships between haeme-requiring periodontal bacteria and haeme-sequestering serum proteins
Reddigari Reply to the letter of B. Lämmle
DK563886A (da) Terapeutisk komposition
ATE99692T1 (de) Optisch aktive rhodiumkomplexe von 3,4bis(diarylphosphino)-pyrrolidinen und ihre verwendung zur herstellung von phosphinothricin durch asymmetrische hydrierung.
IT1216188B (it) Strumento indicatore del grado di abbronzatura dell'epidermide.
RO95371B1 (ro) Medicament pentru tratamentul unor afectiuni alergice cronice

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DSM N.V., HEERLEN, NL

8327 Change in the person/name/address of the patent owner

Owner name: DSM IP ASSETS B.V., HEERLEN, NL

8339 Ceased/non-payment of the annual fee